Published in AIDS Weekly, August 12th, 2002
The International HIV Resistance Response Database Initiative, or RDI, will combine data from thousands of HIV patients around the world into a freely accessible database that could enhance the ability of physicians to choose the most effective drugs for their patients.
"The relationship between genetic changes in HIV and response to drug therapy is highly complex and predicting one from the other requires vast amounts of data", said RDI founding member Dr. Brendan Larder, chief scientific officer, Visible Genetics, Inc. "The RDI is the first...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.